The antigen-MHC I-complex is encountered by the T cell receptor (TCR) of CD8+ T cells; however, tumor cells may lose the ability to express cell surface MHC I molecules by intracellular arrest of MHC I or by acquiring defects in the antigen presentation pathways. Here, CD8A is linked to neoplasm.